Cutaneous manifestations in D-2-hydroxyglutaric aciduria type 2 and response to enasidenib therapy
JAAD Case Rep
.
2024 Nov 8:56:11-13.
doi: 10.1016/j.jdcr.2024.10.020.
eCollection 2025 Feb.
Authors
Jennifer Roux
1
,
Gabrielle Brody
2
,
Brandie Metz
3
4
,
Jingyun Gao
2
,
Changrui Xiao
5
6
,
Richard C Chang
6
Affiliations
1
University of California Irvine School of Medicine, Irvine, California.
2
Department of Dermatology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California.
3
Department of Dermatology, Children's Hospital of Orange County, Orange, California.
4
Pediatric Dermatology of Orange County, Irvine, California.
5
Department of Neurology, University of California Irvine, Irvine, California.
6
Metabolic Disorders Division, Children's Hospital of Orange County, Orange, California.
PMID:
39839460
PMCID:
PMC11750430
DOI:
10.1016/j.jdcr.2024.10.020
No abstract available
Keywords:
D-2-hydroxyglutaric aciduria; dermatitis; enasidenib; pediatric.
Publication types
Case Reports